- recruitingPHASE4
HOPE Against Cancer Recurrence in HCC
This study looks at a new way to prepare donor livers for transplant to help prevent cancer recurrence. It compares cooling livers with a special oxygen-rich fluid to the usual cooling method, hoping to reduce the chance of liver cancer coming back after transplant.
United States · Austria · Belgium - recruitingPHASE2
Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC
This study is looking at a new way to treat a type of liver cancer that can't be removed with surgery. It combines two immunotherapy drugs, durvalumab and tremelimumab, with a radiation treatment called Y-90 SIRT. The aim is to see if this combination is safe and effective.
Germany